Scale-up Systems and ScienView Team Up on Process Development
News May 14, 2013
Scale-up Systems Ltd. announced it has entered into a multi-year agreement with ScienView Co. Ltd. to provide DynoChem® software, training and process development support services to the Chinese pharmaceutical industry.
The motivation behind the agreement is to provide a dedicated local presence to help Chinese users to obtain maximum value from DynoChem’s tools. The initial team in the Beijing and Shanghai offices will be led by Dr. Jinjun Wang for Training & Technical Support and Jack Ma on the Business side.
According to Scale-up Systems CEO Dr. Joe Hannon, “We have been looking for a partner in China that, like our company, specialises in working with and understands the needs of the pharma and life sciences industry. We are therefore delighted to be working with ScienView.”
Scale-up Systems COO Dr. Steve Hearn said “What made ScienView stand out to us was the value it placed on hiring high quality training and support staff across multiple domains.”
ScienView’s Vice President of Informatics Services, Dr. Zhen Wang stated, “Many of our clients are pharmaceutical, chemical or CRO companies, and they are delighted to know that DynoChem will be provided to them along with our top-quality support. With the rapidly increasing R&D investments in China, businesses here also face significant challenges on managing costs and reducing pollution. DynoChem is an excellent tool to help them achieve these goals and is complementary to our products and services.”
Jack Ma, Business Development Manager for ScienView, added that “as the founder of the Shanghai Scientific Informatics Salon, a technical networking forum for big pharma, CRO and chemical companies as well as academics, ScienView finds that scientists and engineers here are very interested in new techniques and tools that can be applied successfully to their work and can be effectively supported by a local team.”
Computer bits are binary, with a value of 0 or 1. By contrast, neurons in the brain can have all kinds of different internal states, depending on the input that they received. This allows the brain to process information in a more energy-efficient manner than a computer. A new study hopes to bring the two closer together.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019